Table S1.
Variables | Cases (N=36)
|
Controls (N=72)
|
P-valuea | ||
---|---|---|---|---|---|
Number | % | Number | % | ||
Age range, month | 0.05–72 | 8–72 | 0.496 | ||
Mean ± SD | 20.25±20.73 | 23.58±15.36 | |||
≤18 | 20 | 55.56 | 35 | 48.61 | |
>18 | 16 | 44.44 | 37 | 51.39 | |
Gender | 1.000 | ||||
Female | 17 | 47.22 | 34 | 47.22 | |
Male | 19 | 52.78 | 38 | 52.78 | |
Clinical stages | |||||
I | 15 | 41.67 | – | – | |
II | 2 | 5.56 | – | – | |
III | 9 | 25.00 | – | – | |
IV | 7 | 19.44 | – | – | |
4s | 3 | 8.33 | – | – | |
Sites of origin | |||||
Adrenal gland | 11 | 30.56 | – | – | |
Retroperitoneal region | 9 | 25.00 | – | – | |
Mediastinum | 14 | 38.89 | – | – | |
Other regions | 2 | 5.56 | – | – |
Notes:
Two-sided χ2 test for distributions between neuroblastoma patients and controls. “–” indicates no value.